驰宏锌锗：10月24日召开董事会会议

Group 1 - The core point of the article is that Chihong Zn & Ge Co., Ltd. held its 26th meeting of the 8th board of directors on October 24, 2025, to review the proposal for the company's Q3 2025 report [1] - For the first half of 2025, the revenue composition of Chihong Zn & Ge was as follows: non-ferrous metal mining and smelting accounted for 73.82%, other businesses accounted for 15.0%, and non-ferrous metal product trading accounted for 11.18% [1] - As of the report date, the market capitalization of Chihong Zn & Ge is 34.2 billion yuan [1] Group 2 - The article also mentions that Chinese innovative drugs have generated $80 billion in overseas licensing this year, highlighting a contrast between the hot secondary market in biomedicine and the cooling fundraising in the primary market [1]